Jasbir Moore – Research output — University of Birmingham

View Scopus Profile

Research activity per year

6 Article
4 Paper
1 Abstract

6 results

Filter

2017
IRP2 As A Potential Modulator Of Cell Proliferation, Apoptosis And Prognosis In Non Small Cell Lung Cancer
Khiroya, H., Moore, J., Ahmad, N., Kay, J., Woolnough, K., Langman, G., Ismail, I., Naidu, B., Tselepis, C. & Turner, A., 2017, In: European Respiratory Journal. 49, 1600711.
Research output: Contribution to journal › Article › peer-review

Open Access
File
15 Citations (Scopus)

180 Downloads (Pure)
2005
Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function
Quinkler, M., Zehnder, D., Lepenies, J., Petrelli, MD., Moore, J., Hughes, S., Cockwell, P., Hewison, M. & Stewart, P., 1 Aug 2005, In: European Journal of Endocrinology. 153, 2, p. 291-299 9 p.
Research output: Contribution to journal › Article
31 Citations (Scopus)
2004
PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro
Boelaert, K., Yu, R., Tannahill, L., Stratford, A., Khanim, F., Eggo, M., Moore, J., Young, L., Gittoes, N., Franklyn, J., Melmed, S. & McCabe, C., 3 Sept 2004, In: Journal of Molecular Endocrinology. 33, 3, p. 663-677 15 p.
Research output: Contribution to journal › Article
33 Citations (Scopus)
Weight loss increases 11 beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
Tomlinson, J., Moore, J., Clark, PM., Holder, G., Shakespeare, L. & Stewart, P., 1 Jan 2004, In: Journal of Clinical Endocrinology and Metabolism. 89, 6, p. 2711-2716 6 p.
Research output: Contribution to journal › Article
72 Citations (Scopus)
2001
Regulation of expression of 11b-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue specific induction by cytokines
Tomlinson, J., Moore, J., Cooper, M., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M. & Stewart, P., 1 May 2001, In: Endocrinology. 142, 5, p. 1982-1989 8 p.
Research output: Contribution to journal › Article
Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analgos incombination with either sodium butyrate or trichostatin A
Rashid, SF., Moore, J., Walker, E., Driver, P., Engel, J., Edwards, CE., Brown, G., Uskokovic, MR. & Campbell, M., 5 Apr 2001, In: Oncogene. 20, 15, p. 1860-1872 13 p.
Research output: Contribution to journal › Article
106 Citations (Scopus)